title: Golden hamster embryonic genome activation occurs at the two-cell stage: correlation with major developmental changes.
abstract: The earliest time of onset of embryonic genome activation in golden hamsters was investigated. The inhibition of transcription by alpha-amanitin (11 micrograms/ml) in cultured embryos resulted in a total arrest of development of early 2-cell embryos (26 hr post-egg activation); under similar conditions, immediate cleavage divisions of 1-, late 2-, 4-, and 8-cell embryos were not affected. Electrophoretic analysis of [35S]methionine-labeled embryonic proteins showed that alpha-amanitin treatment apparently inhibited transcription-dependent protein synthesis in early 2-cell and, to some extent, in late 2-cell when compared to 4-cell embryos. Analysis of total RNA synthesis, using [alpha 32P]-UTP or [32P]-orthophosphate, showed that there was a high proportion of radioactivity associated with the macromolecular fraction (RNA) at the early and late 2-cell stages and at the 4-cell stage compared to that at the 1-cell stage. These results indicate that the de novo synthesis of RNA, encoded by the embryonic genome, occurs at the 2-cell stage and that the second and subsequent cleavage divisions of hamster preimplantation embryos are dependent on new transcriptional activity. This initial activity of the embryonic genome in hamsters is coincident with several characteristic features of in vitro development such as a block to development, synthesis of major proteins, change in energy substrate preference, phosphate-inhibition of development and a requirement for amino acids.
authors.affiliation: Primate Research Center, University of Wisconsin, Madison 53715.
authors.forename: P B
authors.initials: PB
authors.lastname: Seshagiri
authors.forename: D I
authors.initials: DI
authors.lastname: McKenzie
authors.forename: B D
authors.initials: BD
authors.lastname: Bavister
authors.forename: J L
authors.initials: JL
authors.lastname: Williamson
authors.forename: J M
authors.initials: JM
authors.lastname: Aiken
mesh_terms: D000546:Amanitins / Q000494:pharmacology; D000818:Animals; D001755:Blastocyst / Q000378:metabolism; D002970:Cleavage Stage, Ovum / Q000378:metabolism*; D006224:Cricetinae; D005314:Embryonic and Fetal Development / Q000235:genetics*; D005260:Female; D005786:Gene Expression Regulation; D008647:Mesocricetus / Q000196:embryology* / Q000235:genetics; D014158:Transcription, Genetic / Q000187:drug effects
chemical_list: D000546:Amanitins